The research team of Prof. Zhongjun Li and Prof. Zhongtang Li has made progress in the development of heparanase inhibitors and the study of their anti-tumor metastasis activity
School of Pharmaceutical Sciences, Peking University Health Science Center
School of Pharmaceutical Sciences, Peking University Health Science Center
School of Pharmaceutical Sciences, Peking University Health Science Center. The research team of Prof. Zhongjun Li and Prof. Zhongtang Li has made progress in the development of heparanase inhibitors and the study of their anti-tumor metastasis activity[J]. Journal of Chinese Pharmaceutical Sciences, 2025, 34(10): 976-976.
>
>